2021
DOI: 10.1002/ange.202114146
|View full text |Cite
|
Sign up to set email alerts
|

Mechanochemical Solvent‐Free Suzuki–Miyaura Cross‐Coupling of Amides via Highly Chemoselective N−C Cleavage

Abstract: Although cross-coupling reactions of amides by selective NÀ C cleavage are one of the most powerful and burgeoning areas in organic synthesis due to the ubiquity of amide bonds, the development of mechanochemical, solidstate methods remains a major challenge. Herein, we report the first mechanochemical strategy for highly chemoselective, solvent-free palladium-catalyzed cross-coupling of amides by NÀ C bond activation. The method is conducted in the absence of external heating, for short reaction time and show… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 97 publications
0
1
0
Order By: Relevance
“…28 It has also been utilized to modify and enhance the activity of natural products and pharmaceuticals in late stages to achieve better yields and chemoselectivity. [29][30][31] Our research team employed SMC coupling to synthesize carboxamides and carboxylate derivatives, which were then tested for their in-vitro anti-bacterial properties against WHO-listed extremely resistant bacterial strains, aiming to identify potential therapeutic candidates. [32][33][34][35] In the present study, both the ESBL producing E. coli and MRSA were resistant to commonly used antibiotics including penicillins, cephalosporins, and beta-lactam inhibitors.…”
Section: Discussionmentioning
confidence: 99%
“…28 It has also been utilized to modify and enhance the activity of natural products and pharmaceuticals in late stages to achieve better yields and chemoselectivity. [29][30][31] Our research team employed SMC coupling to synthesize carboxamides and carboxylate derivatives, which were then tested for their in-vitro anti-bacterial properties against WHO-listed extremely resistant bacterial strains, aiming to identify potential therapeutic candidates. [32][33][34][35] In the present study, both the ESBL producing E. coli and MRSA were resistant to commonly used antibiotics including penicillins, cephalosporins, and beta-lactam inhibitors.…”
Section: Discussionmentioning
confidence: 99%